Dietary zinc reduces osteoclast resorption activities and increases markers of osteoblast differentiation, matrix maturation, and mineralization in the long bones of growing rats

Journal of Nutritional Biochemistry

Volumn 21, Issue 4, 2010, Pages 297-303

  Hadley, Kevin B ^a   Newman, Samuel M ^a   Hunt, Janet R ^a  

^a GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Bone; Extracellular matrix; Rats; Resorption; Zinc

Indexed keywords

ALKALINE PHOSPHATASE; CARBONATE DEHYDRATASE II; CARRIER PROTEIN; CELL MARKER; COLLAGEN TYPE 1; GELATINASE A; GELATINASE B; MESSENGER RNA; METALLOTHIONEIN I; OSTEOCALCIN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT1; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; ZINC; ZINC SOLUTE CARRIER PROTEIN 39A2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MATRIX; BONE MATURATION; BONE MINERALIZATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DIET THERAPY; ENZYME ACTIVITY; MALE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PROTEIN EXPRESSION; RAT; TRABECULAR BONE; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; BONE DEVELOPMENT; BONE MATRIX; BONE RESORPTION; CALCIFICATION, PHYSIOLOGIC; CATION TRANSPORT PROTEINS; CELL DIFFERENTIATION; DIET; FEMUR; GENE EXPRESSION REGULATION; GROWTH PLATE; MALE; METALLOTHIONEIN; OSTEOCALCIN; OSTEOCLASTS; RANDOM ALLOCATION; RATS; RNA, MESSENGER; TIBIA; ZINC;

RATTUS;

EID: 77649273157     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.01.002     Document Type: Article

References (78)

1. Follis R.H., Day R.G., and McCollum E.V. Histological studies of the tissues of rats fed a diet extremely low in zinc. J Nutr 22 (1941) 223-237
2. O'Dell B.L., Newberne P.M., and Savage J.E. Significance of dietary zinc for the growing chicken. J Nutr 65 (1958) 503-518
3. Rossi L., Migliaccio S., Corsi A., Marzia M., Bianco P., Teti A., et al. Reduced growth and skeletal changes in zinc-deficient growing rats are due to impaired growth plate activity and inanition. J Nutr 131 (2001) 1142-1146
4. Zhang Y., Cheng Y., Hong Y., and Li S. Zinc deficiency on pathological changes of femur epiphyseal growth plate in rats. Wei Sheng Yan Jiu 32 (2003) 16-19
5. da Cunha Ferreira R.M., Rodriguez Gonzalez J.I., Monreal Marquiegui I., and Villa Elizaga I. Changes in the fetal tibial growth plate secondary to maternal zinc deficiency in the rat: a histological and histochemical study. Teratology 44 (1991) 441-451
6. Suwarnasarn A., Wallwork J.C., Lykken G.I., Low F.N., and Sandstead H.H. Epiphyseal plate development in the zinc-deficient rat. J Nutr 112 (1982) 1320-1328
7. Eberle J., Schmidmayer S., Erben R.G., Stangassinger M., and Roth H.P. Skeletal effects of zinc deficiency in growing rats. J Trace Elem Med Biol 13 (1999) 21-26
8. Oner G., Bhaumick B., and Bala R.M. Effect of zinc deficiency on serum somatomedin levels and skeletal growth in young rats. Endocrinology 114 (1984) 1860-1863
9. Hunt J.R., and Johnson L.K. Dietary protein, as egg albumen: effects on bone composition, zinc bioavailability and zinc requirements of rats, assessed by a modified broken-line model. J Nutr 122 (1992) 161-169
10. Ovesen J., Moller-Madsen B., Thomsen J.S., Danscher G., and Mosekilde L. The positive effects of zinc on skeletal strength in growing rats. Bone 29 (2001) 565-570
11. Becker W.M., and Hoekstra W.G. Effect of vitamin D on 65Zn absorption, distribution and turnover in rats. J Nutr 90 (1966) 301-309
12. Hurley L.S., Gowan J., and Milhaud G. Calcium metabolism in manganese-deficient and zinc-deficient rats. Proc Soc Exp Biol Med 130 (1969) 856-860
13. Holloway W.R., Collier F.M., Herbst R.E., Hodge J.M., and Nicholson G.C. Osteoblast-mediated effects of zinc on isolated rat osteoclasts: inhibition of bone resorption and enhancement of osteoclast number. Bone 19 (1996) 137-142
14. Vallee B.L., and Falchuk K.H. The biochemical basis of zinc physiology. Physiol Rev 73 (1993) 79-118
15. Wilhelm S.M., Collier I.E., Marmer B.L., Eisen A.Z., Grant G.A., and Goldberg G.I. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264 (1989) 17213-17221
16. Collier I.E., Wilhelm S.M., Eisen A.Z., Marmer B.L., Grant G.A., Seltzer J.L., et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 263 (1988) 6579-6587
17. Pocker Y., and Sarkanen S. Carbonic anhydrase: structure catalytic versatility, and inhibition. Adv Enzymol Relat Areas Mol Biol 47 (1978) 149-274
18. Susi F.R., Goldhaber P., and Jennings J.M. Histochemical and biochemical study of acid phosphatase in resorbing bone in culture. Am J Physiol 211 (1966) 959-962
19. Miller S.C. The rapid appearance of acid phosphatase activity at the developing ruffled border of parathyroid hormone activated medullary bone osteoclasts. Calcif Tissue Int 37 (1985) 526-529
20. Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 34 (1982) 285-290
21. Reeves P.G. AIN-93 purified diets for the study of trace element metabolism in rodents. In: Watson R.R. (Ed). Trace Elements in Laboratory Rodents (1996), CRC Press, Inc., Boca Raton, FL 3-37
22. Eeckhout Y., Delaisse J.M., and Vaes G. Direct extraction and assay of bone tissue collagenase and its relation to parathyroid-hormone-induced bone resorption. Biochem J 239 (1986) 793-796
23. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
24. Lau K.H., Onishi T., Wergedal J.E., Singer F.R., and Baylink D.J. Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption. Clin Chem 33 (1987) 458-462
25. Bessey O.A., Lowry O.H., and Brock M.J. A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. J Biol Chem 164 (1946) 321-329
26. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., et al. Current protocols in molecular biology (1995), John Wiley & Sons, New York, NY
27. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 (2001) e45
28. Oda N., Sogawa C.A., Sogawa N., Onodera K., Furuta H., and Yamamoto T. Metallothionein expression and localization in rat bone tissue after cadmium injection. Toxicol Lett 123 (2001) 143-150
29. Hyun T.H., Barrett-Connor E., and Milne D.B. Zinc intakes and plasma concentrations in men with osteoporosis: the Rancho Bernardo Study. Am J Clin Nutr 80 (2004) 715-721
30. Elmstahl S., Gullberg B., Janzon L., Johnell O., and Elmstahl B. Increased incidence of fractures in middle-aged and elderly men with low intakes of phosphorus and zinc. Osteoporos Int 8 (1998) 333-340
31. Freudenheim J.L., Johnson N.E., and Smith E.L. Relationships between usual nutrient intake and bone-mineral content of women 35-65 years of age: longitudinal and cross-sectional analysis. Am J Clin Nutr 44 (1986) 863-876
32. Strause L., Saltman P., Smith K.T., Bracker M., and Andon M.B. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr 124 (1994) 1060-1064
33. Saltman P.D., and Strause L.G. The role of trace minerals in osteoporosis. J Am Coll Nutr 12 (1993) 384-389
34. Herzberg M., Lusky A., Blonder J., and Frenkel Y. The effect of estrogen replacement therapy on zinc in serum and urine. Obstet Gynecol 87 (1996) 1035-1040
35. Herzberg M., Foldes J., Steinberg R., and Menczel J. Zinc excretion in osteoporotic women. J Bone Miner Res 5 (1990) 251-257
36. Relea P., Revilla M., Ripoll E., Arribas I., Villa L.F., and Rico H. Zinc, biochemical markers of nutrition, and type I osteoporosis. Age Ageing 24 (1995) 303-307
37. Roughead Z.K., and Lukaski H.C. Inadequate copper intake reduces serum insulin-like growth factor-I and bone strength in growing rats fed graded amounts of copper and zinc. J Nutr 133 (2003) 442-448
38. Hosea H.J., Taylor C.G., Wood T., Mollard R., and Weiler H.A. Zinc-deficient rats have more limited bone recovery during repletion than diet-restricted rats. Exp Biol Med (Maywood) 229 (2004) 303-311
39. Pallauf J., and Kirchgessner M. Zinkgehalte in knochen und ganzkorper wachsender ratten bei unterschiedlicher zinkversorgung. Z Tierphysiol, Tierernahrg u Futtermittelkde 30 (1972) 193-202
40. Momcilovic B., Reeves P.G., and Blake M.J. Idiorrhythmic dose-rate variability in dietary zinc intake generates a different response pattern of zinc metabolism than conventional dose-response feeding. Br J Nutr 78 (1997) 173-191
41. Essatara M.B., Levine A.S., Morley J.E., and McClain C.J. Zinc deficiency and anorexia in rats: normal feeding patterns and stress induced feeding. Physiol Behav 32 (1984) 469-474
42. Evans S.A., Overton J.M., Alshingiti A., and Levenson C.W. Regulation of metabolic rate and substrate utilization by zinc deficiency. Metabolism 53 (2004) 727-732
43. Kennedy K.J., Rains T.M., and Shay N.F. Zinc deficiency changes preferred macronutrient intake in subpopulations of Sprague-Dawley outbred rats and reduces hepatic pyruvate kinase gene expression. J Nutr 128 (1998) 43-49
44. Moonga B.S., and Dempster D.W. Zinc is a potent inhibitor of osteoclastic bone resorption in vitro. J Bone Miner Res 10 (1995) 453-457
45. Tezuka K., Nemoto K., Tezuka Y., Sato T., Ikeda Y., Kobori M., et al. Identification of matrix metalloproteinase 9 in rabbit osteoclasts. J Biol Chem 269 (1994) 15006-15009
46. Reponen P., Sahlberg C., Munaut C., Thesleff I., and Tryggvason K. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol 124 (1994) 1091-1102
47. Huang W.H., Lau A.T., Daniels L.L., Fujii H., Seydel U., Wood D.J., et al. Detection of estrogen receptor alpha, carbonic anhydrase II and tartrate-resistant acid phosphatase mRNAs in putative mononuclear osteoclast precursor cells of neonatal rats by fluorescence in situ hybridization. J Mol Endocrinol 20 (1998) 211-219
48. Takeshita S., Kaji K., and Kudo A. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res 15 (2000) 1477-1488
49. Matsuo K., Galson D.L., Zhao C., Peng L., Laplace C., Wang K.Z., et al. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem 279 (2004) 26475-26480
50. Okada Y., Naka K., Kawamura K., Matsumoto T., Nakanishi I., Fujimoto N., et al. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/Type IV collagenase=gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest 72 (1995) 311-322
51. Kusano K., Miyaura C., Inada M., Tamura T., Ito A., Nagase H., et al. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology 139 (1998) 1338-1345
52. Sly W.S., Hewett-Emmett D., Whyte M.P., Yu Y.S., and Tashian R.E. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci U S A 80 (1983) 2752-2756
53. Waite L.C. Carbonic anhydrase inhibitors, parathyroid hormone and calcium metabolism. Endocrinology 91 (1972) 1160-1165
54. Gay C.V., and Mueller W.J. Carbonic anhydrase and osteoclasts: localization by labeled inhibitor autoradiography. Science 183 (1974) 432-434
55. Zaidi M., Moonga B., Moss D.W., and MacIntyre I. Inhibition of osteoclastic acid phosphatase abolishes bone resorption. Biochem Biophys Res Commun 159 (1989) 68-71
56. Roth D.E., Venta P.J., Tashian R.E., and Sly W.S. Molecular basis of human carbonic anhydrase II deficiency. Proc Natl Acad Sci U S A 89 (1992) 1804-1808
57. Lehenkari P., Hentunen T.A., Laitala-Leinonen T., Tuukkanen J., and Vaananen H.K. Carbonic anhydrase II plays a major role in osteoclast differentiation and bone resorption by effecting the steady state intracellular pH and Ca2+. Exp Cell Res 242 (1998) 128-137
58. Schlesinger P.H., Mattsson J.P., and Blair H.C. Osteoclastic acid transport: mechanism and implications for physiological and pharmacological regulation. Miner Electrolyte Metab 20 (1994) 31-39
59. Aimes R.T., and Quigley J.P. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem 270 (1995) 5872-5876
60. Vu T.H., Shipley J.M., Bergers G., Berger J.E., Helms J.A., Hanahan D., et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93 (1998) 411-422
61. Engsig M.T., Chen Q.J., Vu T.H., Pedersen A.C., Therkidsen B., Lund L.R., et al. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 151 (2000) 879-889
62. Fang J., Shing Y., Wiederschain D., Yan L., Butterfield C., Jackson G., et al. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci U S A 97 (2000) 3884-3889
63. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3 (2002) 889-901
64. Raisz L.G., and Kream B.E. Regulation of bone formation. N Engl J Med 309 (1983) 83-89
65. Quarles L.D., Yohay D.A., Lever L.W., Caton R., and Wenstrup R.J. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res 7 (1992) 683-692
66. Gehron-Robey P. Principles of Bone Biology (1996), Academic Press, San Diego, CA
67. Byers P.H. Brittle bones-fragile molecules: disorders of collagen gene structure and expression. Trends Genet 6 (1990) 293-300
68. Owen T.A., Aronow M., Shalhoub V., Barone L.M., Wilming L., Tassinari M.S., et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143 (1990) 420-430
69. Stein G.S., Lian J.B., and Owen T.A. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 4 (1990) 3111-3123
70. Weinreb M., Shinar D., and Rodan G.A. Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization. J Bone Miner Res 5 (1990) 831-842
71. McCabe L.R., Kockx M., Lian J., Stein J., and Stein G. Selective expression of fos- and jun-related genes during osteoblast proliferation and differentiation. Exp Cell Res 218 (1995) 255-262
72. Ducy P., Desbois C., Boyce B., Pinero G., Story B., Dunstan C., et al. Increased bone formation in osteocalcin-deficient mice. Nature 382 (1996) 448-452
73. Fedde K.N., Blair L., Silverstein J., Coburn S.P., Ryan L.M., Weinstein R.S., et al. Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 14 (1999) 2015-2026
74. Anderson H.C., Sipe J.B., Hessle L., Dhanyamraju R., Atti E., Camacho N.P., et al. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol 164 (2004) 841-847
75. Ducy P., Starbuck M., Priemel M., Shen J., Pinero G., Geoffroy V., et al. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 13 (1999) 1025-1036
76. Ducy P. Cbfa1: a molecular switch in osteoblast biology. Dev Dyn 219 (2000) 461-471
77. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
78. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89 (1997) 765-771